Specialising in ophthalmic surgery since its inception almost 30 years ago, I-MED Pharma is proud of our long-standing partnerships with leading global suppliers such as Moria, Geuder and Rayner. With a focus on corneal surgery, we are committed to delivering high quality, high impact and innovative solutions to ophthalmologists around the world.
I-MED Pharma looks forward to working with you to offer “Best in Class” solutions to better diagnose and treat dry eye disease. Our experienced and professional sales team can help you integrate a dry eye protocol into your practice. Our products are sold directly to eye care professionals and a network of distributors exclusively.
I-MED Pharma, Your Partner In Eye Care
I-MED Pharma innovates and distributes medical, surgical and veterinary eye care products. Our mission is simple, yet challenging: perfecting sight. To achieve this, we continually conduct research, develop and source the most effective and advanced solutions to eye disorders like cataracts, corneal transplants, dry eye, and glaucoma. Our goal is to provide our customers with leading-edge diagnostics and high impact treatment solutions for a wide range of ocular surface diseases.
Our uniquely formulated line of Ocular Surface Disorder products gives your dry eye patients the long-lasting relief they are searching for. We provide a comprehensive offering in the way of viscoadaptive artificial tears, ocular hygiene, punctal plugs and state-of-the-art diagnostic tools. We invite you to learn more about our OSD line and why it is unique, along with our other industry leading division, I-MED Animal Health.
Latest News & Events
Montreal, April 3, 2018 (Globe Newswire) – I-MED Pharma Inc., a Canadian Company specializing in…
I-MED Animal Health
With close to 30 years of proven results, I-MED Animal Health, a division of I-MED Pharma Inc., dedicates itself to improving the ocular health of companion animals by delivering the highest quality veterinary OSD, OVD, Diagnostic and Surgical product offering on the market.